Adlina-EM 25 mg+5 mg (Tablet)
Unit Price: ৳ 40.00 (1 x 10: ৳ 400.00)
Strip Price: ৳ 400.00
Medicine Details
Category | Details |
---|---|
Generic | Empagliflozin linagliptin |
Company | Unimed unihealth pharmaceuticals ltd |
Also available as |
Indications
- Adjunct to diet and exercise
- Improves glycemic control
- Type 2 diabetes mellitus
Pharmacology
- Inhibits DPP-4 enzyme
- Increases active incretin hormones
- Stimulates insulin release
- Reduces glucagon levels
- Inhibitor of Sodium-glucose co-transporter 2
- Increases urinary glucose excretion
Dosage & Administration
- Recommended dose: 10 mg Empagliflozin and 5 mg Linagliptin once daily
- Increased dose: 25 mg Empagliflozin and 5 mg Linagliptin once daily
- Renal impaired patients assessment
Interaction
- Diuretics coadministration
- Insulin or Insulin Secretagogues coadministration
- Inducers of P-glycoprotein or CYP3A4 Enzymes
- Positive Urine Glucose Test
- Interference with 1,5-anhydroglucitol (1,5-AG) Assay
Contraindications
- Severe renal impairment
- Hypersensitivity reaction to Linagliptin
- Hypersensitivity reaction to Empagliflozin
Side Effects
- Pancreatitis
- Ketoacidosis
- Volume Depletion
- Urosepsis and Pyelonephritis
- Hypoglycemia with Concomitant Use with Insulin and Insulin Secretagogues
- Necrotizing Fasciitis of the Perineum
- Genital Mycotic Infections
- Hypersensitivity Reactions
- Severe and Disabling Arthralgia
- Bullous Pemphigoid
- Heart Failure
Pregnancy & Lactation
- Not recommended during second and third trimesters
- Limited available data
- Risks to mother and fetus
Precautions & Warnings
- Pancreatitis
- Hypotension
- Ketoacidosis
- Acute kidney injury
- Urosepsis and Pyelonephritis
- Genital Mycotic Infections
- Hypersensitivity
- Necrotizing Fasciitis of the Perineum
- Heart Failure
Overdose Effects
- Contact Poison Control Center
- Supportive measures
- Hemodialysis study
Therapeutic Class
- Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors
Storage Conditions
- Store below 30°C
- Keep away from light and wet place
- Keep out of reach of children